ATE550043T1 - Biologische schrittmacher mit mutierten hyperpolarisierungsaktivierten zyklischen nukleotid-gekoppelte (hcn) kanälen - Google Patents

Biologische schrittmacher mit mutierten hyperpolarisierungsaktivierten zyklischen nukleotid-gekoppelte (hcn) kanälen

Info

Publication number
ATE550043T1
ATE550043T1 AT07868852T AT07868852T ATE550043T1 AT E550043 T1 ATE550043 T1 AT E550043T1 AT 07868852 T AT07868852 T AT 07868852T AT 07868852 T AT07868852 T AT 07868852T AT E550043 T1 ATE550043 T1 AT E550043T1
Authority
AT
Austria
Prior art keywords
hcn
hyperpolarization
cyclic nucleotide
mutant
channels
Prior art date
Application number
AT07868852T
Other languages
English (en)
Inventor
Daniel C Sigg
Vinod Sharma
Yong-Fu Xiao
Original Assignee
Medtronic Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medtronic Inc filed Critical Medtronic Inc
Application granted granted Critical
Publication of ATE550043T1 publication Critical patent/ATE550043T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A61K48/005—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'active' part of the composition delivered, i.e. the nucleic acid delivered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Zoology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biotechnology (AREA)
  • Veterinary Medicine (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT07868852T 2006-11-30 2007-11-27 Biologische schrittmacher mit mutierten hyperpolarisierungsaktivierten zyklischen nukleotid-gekoppelte (hcn) kanälen ATE550043T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11/565,433 US8076305B2 (en) 2006-11-30 2006-11-30 Biological pacemakers including mutated hyperpolarization-activated cyclic nucleotide-gated (HCN) channels
PCT/US2007/085576 WO2008067279A2 (en) 2006-11-30 2007-11-27 Biological pacemakers including mutated hyperpolarization-activated cyclic nucleotide-gated (hcn) channels

Publications (1)

Publication Number Publication Date
ATE550043T1 true ATE550043T1 (de) 2012-04-15

Family

ID=39471819

Family Applications (1)

Application Number Title Priority Date Filing Date
AT07868852T ATE550043T1 (de) 2006-11-30 2007-11-27 Biologische schrittmacher mit mutierten hyperpolarisierungsaktivierten zyklischen nukleotid-gekoppelte (hcn) kanälen

Country Status (4)

Country Link
US (1) US8076305B2 (de)
EP (1) EP2097110B1 (de)
AT (1) ATE550043T1 (de)
WO (1) WO2008067279A2 (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11660317B2 (en) 2004-11-08 2023-05-30 The Johns Hopkins University Compositions comprising cardiosphere-derived cells for use in cell therapy
US8076305B2 (en) 2006-11-30 2011-12-13 Medtronic, Inc. Biological pacemakers including mutated hyperpolarization-activated cyclic nucleotide-gated (HCN) channels
US20120322861A1 (en) * 2007-02-23 2012-12-20 Barry John Byrne Compositions and Methods for Treating Diseases
US8442631B2 (en) * 2007-05-08 2013-05-14 Cardiac Pacemakers, Inc. System and method for determining the origin of a sensed beat
EP2405933A1 (de) * 2009-03-13 2012-01-18 Medtronic, Inc Verfahren zur behandlung von herzinsuffizienz
US20110144028A1 (en) * 2009-12-11 2011-06-16 Vinod Sharma Modulating cellular electrophysiology
US20110301568A1 (en) 2010-06-04 2011-12-08 Medtronic, Inc. Systems and Methods to Treat Cardiac Pacing Conditions
US8639323B2 (en) * 2010-11-01 2014-01-28 Medtronic, Inc. System and apparatus to monitor biopacemaker maturation
JP6236393B2 (ja) 2011-11-09 2017-11-22 セダーズ−シナイ メディカル センター 転写因子に基づくペースメーカー細胞の生成およびその使用方法
AU2013302799B2 (en) 2012-08-13 2018-03-01 Cedars-Sinai Medical Center Exosomes and micro-ribonucleic acids for tissue regeneration
CA2893692C (en) * 2012-12-04 2019-06-25 Exxonmobil Research And Engineering Company Tetraselmis promoters and terminators for use in eukaryotic cells
EP3021946A2 (de) * 2013-07-16 2016-05-25 Karakossian, Movses Hcn-inhibitoren mit auswirkung auf die ganglienzellenfunktion und visuelle funktion
WO2016054591A1 (en) 2014-10-03 2016-04-07 Cedars-Sinai Medical Center Cardiosphere-derived cells and exosomes secreted by such cells in the treatment of muscular dystrophy
US11253551B2 (en) 2016-01-11 2022-02-22 Cedars-Sinai Medical Center Cardiosphere-derived cells and exosomes secreted by such cells in the treatment of heart failure with preserved ejection fraction
WO2017210652A1 (en) 2016-06-03 2017-12-07 Cedars-Sinai Medical Center Cdc-derived exosomes for treatment of ventricular tachyarrythmias
EP3515459A4 (de) 2016-09-20 2020-08-05 Cedars-Sinai Medical Center Kardiosphärenzellen und deren extrazelluläre vesikel zur verzögerung oder umkehr des alterungsprozesses und altersbedingten erkrankungen
CA3059910A1 (en) 2017-04-19 2018-10-25 Cedars-Sinai Medical Center Methods and compositions for treating skeletal muscular dystrophy
WO2019126068A1 (en) 2017-12-20 2019-06-27 Cedars-Sinai Medical Center Engineered extracellular vesicles for enhanced tissue delivery
WO2019152549A1 (en) 2018-02-05 2019-08-08 Cedars-Sinai Medical Center Methods for therapeutic use of exosomes and y-rnas
CN109173057B (zh) * 2018-06-07 2022-06-03 深圳市太空科技南方研究院 生物起搏器模型构建方法及终端设备

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL158618A0 (en) * 2001-04-27 2004-05-12 Univ Johns Hopkins Biological pacemaker
US6849611B2 (en) 2001-06-06 2005-02-01 The Trustees Of Columbia University In The City Of New York Implantation of biological pacemaker that is molecularly determined
US6718204B2 (en) * 2001-07-30 2004-04-06 Medtronic, Inc. Method and apparatus to control delivery of high-voltage and anti-tachy pacing therapy in an implantable medical device
US7142928B2 (en) * 2001-12-03 2006-11-28 Medtronic, Inc. Field stimulation about a discontinuity of the myocardium to capture the heart at reduced pacing thresholds
US7177680B2 (en) * 2001-12-03 2007-02-13 Medtronic, Inc. Field stimulation about a discontinuity of the myocardium to capture the heart at reduced pacing thresholds
US6922585B2 (en) * 2002-04-05 2005-07-26 Medtronic, Inc. Method and apparatus for predicting recurring ventricular arrhythmias
US6892094B2 (en) * 2002-04-30 2005-05-10 Medtronic, Inc. Combined anti-tachycardia pacing (ATP) and high voltage therapy for treating ventricular arrhythmias
US7415307B2 (en) * 2002-10-31 2008-08-19 Medtronic, Inc. Ischemia detection based on cardiac conduction time
US7149577B2 (en) * 2002-12-02 2006-12-12 Medtronic, Inc. Apparatus and method using ATP return cycle length for arrhythmia discrimination
US7794702B2 (en) 2003-01-15 2010-09-14 The Trustees Of Columbia University In The City Of New York Mesenchymal stem cells as a vehicle for ion channel transfer in syncytial structures
US7107098B2 (en) * 2003-02-20 2006-09-12 Medtronic, Inc. Method and apparatus for generation and selection of tachycardia therapy hierarchy
US8013133B2 (en) * 2003-04-25 2011-09-06 Medtronic, Inc. Genetic modification of targeted regions of the cardiac conduction system
US20040214182A1 (en) * 2003-04-25 2004-10-28 Vinod Sharma Genetic modification of targeted regions of the cardiac conduction system
US20070021375A1 (en) * 2003-04-25 2007-01-25 Vinod Sharma Genetic modification of targeted regions of the cardiac conduction system
US20050021089A1 (en) * 2003-07-24 2005-01-27 Medtronic, Inc. Compositions and methods for treating cardiac dysfunction
US7392082B2 (en) * 2003-09-26 2008-06-24 Medtronic, Inc. Inter-episode implementation of closed loop ATP
US7190993B2 (en) * 2003-11-04 2007-03-13 Medtronic, Inc. Implantable medical device having optical fiber for sensing electrical activity
US8859273B2 (en) * 2003-12-24 2014-10-14 Medtronic, Inc. Methods of using HCN genes to treat cardiac arrhythmias
US7608458B2 (en) * 2004-02-05 2009-10-27 Medtronic, Inc. Identifying patients at risk for life threatening arrhythmias
EP1723432A1 (de) * 2004-02-05 2006-11-22 Medtronic, Inc. Verfahren und vorrichtung zur identifizierung von patienten in gefahr durch lebensbedrohliche arrhythmien
US20060020316A1 (en) * 2004-06-03 2006-01-26 Medtronic, Inc. Implantable cardioversion and defibrillation system including intramural myocardial elecrtode
US20060088503A1 (en) * 2004-10-13 2006-04-27 Vinod Sharma Cellular and genetic intervention to treat ventricular tachycardia
US7515960B2 (en) * 2005-03-31 2009-04-07 Medtronic, Inc. Method and apparatus to terminate ventricular tachycardia via pacing
US8565898B2 (en) * 2005-04-28 2013-10-22 Medtronic, Inc. Rate control during AF using cellular intervention to modulate AV node
US20070087033A1 (en) * 2005-10-14 2007-04-19 Sigg Daniel C Self-fixating scaffolds
US7778705B2 (en) * 2006-10-31 2010-08-17 Medtronic, Inc. Electronic and biological pacemaker systems
US8076305B2 (en) 2006-11-30 2011-12-13 Medtronic, Inc. Biological pacemakers including mutated hyperpolarization-activated cyclic nucleotide-gated (HCN) channels
US8396539B2 (en) * 2007-02-16 2013-03-12 Medtronic, Inc. Implantable medical device having optical fiber for sensing electrical activity
US20090233990A1 (en) * 2007-11-01 2009-09-17 Hee Cheol Cho Generation of biological pacemaker activity

Also Published As

Publication number Publication date
WO2008067279A2 (en) 2008-06-05
EP2097110A2 (de) 2009-09-09
EP2097110B1 (de) 2012-03-21
WO2008067279A3 (en) 2008-12-24
US8076305B2 (en) 2011-12-13
US20090099611A1 (en) 2009-04-16

Similar Documents

Publication Publication Date Title
ATE550043T1 (de) Biologische schrittmacher mit mutierten hyperpolarisierungsaktivierten zyklischen nukleotid-gekoppelte (hcn) kanälen
EP4491214A3 (de) Abgabe von tumorbehandlungsfeldern (ttfields) unter verwendung implantierbarer wandlerarrays
WO2007030743A3 (en) Cochlear implants containing biological cells and uses thereof
PH12014502217A1 (en) Methods for improving diaphragm function
WO2006119069A3 (en) Focused stimulation in a medical stimulation device
ATE341291T1 (de) Transkutane prothese
GB2484873A (en) Differentiation of human embryonic stem cells
ATE530224T1 (de) Gerät und verfahren zur optimierung von atrioventrikulären pacing-verzögerungsintervallen
BR112022001416A2 (pt) Populações de células t gama delta ex vivo
MY175979A (en) Certain chemical entities, compositions and methods
WO2012158486A3 (en) Optimal model constants for simultaneous stimulation with channel interaction compensation
DE602005006414D1 (de) Mittels fettsäureamid-polyole hergestellte polyurethanteppichunterlagen
EP3914274A4 (de) Zusammensetzungen und verfahren zur stimulation von natürlichen killerzellen
TW200621217A (en) Flexible implantable electrical stimulator array
WO2012048170A3 (en) Humanized animals via tissue engineering and uses therefor
EP3761031A4 (de) Verfahren zur isolierung von zellkernen mit erhöhter antigenizität aus immobilisierten zellen oder ffpe-gewebeabschnitten sowie antigenaktivator und kit dafür
MX2007006822A (es) Formulaciones terapeuticas para el factor de crecimiento de queratinocitos.
CY1124082T1 (el) Μεθοδοι θεραπειας με χρηση κινητοποιητων βλαστικων κυτταρων και ανοσοκατασταλτικων παραγοντων
EP1909895A4 (de) Tandem-herzschrittmacher-system
CY1112877T1 (el) Μεταλλαγματα αυξητικου παραγoντα υψηλης δραστικοτητας
CL2025000038A1 (es) Modulación de enzimas y vías con compuestos de sulfhidrilo y sus derivados
ATE483716T1 (de) Lösungsmittelfreies amorphes rapamycin
DK2164536T3 (da) Fremgangsmåde til præparering af et acellulært organisk væv
WO2007005828A3 (en) Cell growth and cell transplant devices for gene therapy
PL1610834T3 (pl) Samoustawiające się prowadnice ułatwiające wzrost tkanek